Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

FDA Warns of Contaminated Illegal Synthetic Marijuana

FDA has become aware of severe illnesses and deaths linked to contaminated synthetic marijuana products that could affect the U.S. blood supply.

FDA Warns of Contaminated Illegal Synthetic Marijuana
FDA Warns of Contaminated Illegal Synthetic Marijuana

A recent FDA Statement warned consumers against illegal synthetic cannabinoid products linked to severe illness and death. Unapproved products sold in convenience stores under names like “K2” and “Spice” have been contaminated with brodifacoum, an anticoagulant commonly used in rat poison formulas. Individuals who have consumed products contaminated with the long-acting anticoagulant could potentially contaminate the U.S. blood supply if they donate blood.

The FDA has worked with the DEA to prevent these illegal synthetic marijuana products from being marketed and sold. However, makers have bypassed state and federal drug laws by labeling these products as “not for human consumption” and altering the structure of the chemicals to dodge legal requirements. Some producers have added brodifacoum, as it’s believed to extend the duration of the “high.” The FDA urges consumers to avoid these products as there is no way of telling which ones have been contaminated with the powerful anticoagulant.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?